Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later: The Era of Vaccines

Impressive efforts have been made by researchers worldwide in the development of target vaccines against the novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and in improving the management of immunomodulating agents. Currently, different vaccine formulations, such as viral vector,...

Descripción completa

Detalles Bibliográficos
Autores principales: Picchianti Diamanti, Andrea, Rosado, Maria Manuela, Nicastri, Emanuele, Sesti, Giorgio, Pioli, Claudio, Laganà, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515900/
https://www.ncbi.nlm.nih.gov/pubmed/34659200
http://dx.doi.org/10.3389/fimmu.2021.708848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515900/
https://www.ncbi.nlm.nih.gov/pubmed/34659200
http://dx.doi.org/10.3389/fimmu.2021.708848

Ejemplares similares